February 17, 2023 06:14 AM ESTUpdated 06:24 AM
Peer Review

Au revoir, Sanofi: John Reed dash­es to J&J; Zen­tal­is plucks new COO from GSK

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Some­thing big had to be brew­ing when Sanofi an­nounced the de­par­ture of R&D chief John Reed bright and ear­ly Mon­day morn­ing. Is he tak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times